Theranos Lays off Over 100 of its Employees

Theranos is continuing its descent into the new year as it makes plans to lay off 40 percent of its workforce and struggles to overcome past compliance issues. The blood-testing company describes its decision to lay off 155 employees as “further re-engineering”, leaving “a core team of 220 professionals to execute on its business plans” according to a statement on the company’s website.

Theranos’ downward motion was first signaled in October after 340 employees were laid off and clinical laboratories and wellness centers were then shut. The company has also faced distrust due to compliance issue allegations by regulators, ultimately leading to the company voiding two years of test results from its blood-testing equipment the year previous. Theranos also lost noted company Walgreens as a business partner and faced lawsuits from patients as well as investors. The company continues to strain against strict sanctions imposed by regulators. Elizabeth Holmes, chief executive of Theranos, is banned for two years from owning or operating a clinical laboratory due to the issues.

Theranos brought in crisis management professionals in December to augment corporate ranks. The blood testing company further shuffled its roster by adding a molecular diagnostic expert to its medical-scientific advisory board and letting go of retired Marine General James Mattis from the board of directors. The down-sized company is now working on getting its minilab testing platform ready for the market.

The company said in a statement that “teams have been aligned to meet product development, regulatory and commercial milestones.” The debut of its minilab testing, however, fell short of reaching its public interest goals, as a scientific conference session held over the summer reminded the crowd of the company’s initial disappointment. The lackluster response can be attributed in part due to Holmes’ silence of why the company’s previous blood-testing device did not work as promised. This omission is especially disappointing to scientists as this device helped make Theranos one of the most sought-after start-ups in the past few years.

About News Team

Hi, I'm Alex Perez, an experienced writer with a focus on lifestyle and culture news. From food and fashion to travel and entertainment, I love exploring the latest trends and sharing my insights with readers. I also have a strong interest in world news and business, and enjoy covering breaking stories and events.

Have a tip we should know?


Most Read

  1. ARTS
    With a Vengeance and no Apologies, Art Basel Miami Beach Has Returned
    2 years ago
  2. Food
    Is Faux Turkey Finally Vegan-Approved for Thanksgiving?
    2 years ago
  3. News
    Pandora Papers Financial Leak Shows Us the Secrets of the World’s Rich and Powerful
    2 years ago
  4. Health
    US Supreme Court Rejects J & J TALC Cancer Case Appeal
    2 years ago
  5. Lifestyle
    9 Habits that Drain your Daily Focus and How to Avoid Them
    2 years ago
    Women’s Demand for Shapewear – the big Trends
    2 years ago
    Valentino Launches its Cosmetics Line
    2 years ago
  8. Business
    McDonald’s Sales Increase Amid COVID Restrictions
    2 years ago
  9. Health
    US Promises to Share 60 million Doses of AstraZeneca Vaccines
    2 years ago
  10. coronavirus
    UK Offers Aid Amid Surging COVID-19 Cases in India
    2 years ago
  11. Entertainment
    Nomadland Director Chloé Zhao, Wins the Best Director in 2021 Oscar
    2 years ago
    Toshiba says $14 billion takeover bid by JIP succeeds, set to go private
    57 mins ago
  13. Europe
    Poland, with election looming, says it isn’t sending new arms to Ukraine
    58 mins ago
  14. Soccer
    England women, FA reach agreement over bonuses, says Bright
    58 mins ago
    China’s economic woes embolden calls for deeper reforms
    2 hours ago
  16. Europe
    Russia hits Ukrainian energy facilities in biggest attack in weeks
    2 hours ago
  17. Sports
    Unique sports at the Asian Games in Hangzhou
    2 hours ago
    Exclusive: China scrutinises quant strategies as market weakness stokes public anger – sources
    3 hours ago

Follow @rushhourdaily: